3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
44
Precursor Cell Lymphoblastic Leukemia-Lymphoma
23
Leukemia
19
Leukemia, Myelomonocytic, Acute
11
Leukemia, Monocytic, Acute
10
Leukemia, Erythroblastic, Acute
9
Congenital Abnormalities
8
Leukemia, Megakaryoblastic, Acute
7
Burkitt Lymphoma
6
Myelodysplastic Syndromes
4
Leukemia, Eosinophilic, Acute
4
Myeloproliferative Disorders
3
Lymphoma
3
Leukemia, Biphenotypic, Acute
3
Leukemia, Basophilic, Acute
3
Recurrence
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Hematologic Neoplasms
2
Thrombocytopenia
1
Thrombocythemia, Essential
1
Sarcoma, Myeloid
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Lymphoproliferative Disorders
1
Lymphoma, Non-Hodgkin
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Immunoproliferative Disorders
1
Interventions
Rituximab
4
blinatumomab
3
Whole-Body Irradiation
3
Cyclophosphamide
3
fludarabine phosphate
2
Mycophenolic Acid
2
Melphalan
2
Lenalidomide
2
Clofarabine
2
treosulfan
1
thymoglobulin
1
sabatolimab
1
pembrolizumab
1
peginterferon alfa-2a
1
obinutuzumab
1
midostaurin
1
ixazomib
1
fludarabine
1
eribulin
1
daratumumab
1
acalabrutinib
1
Trastuzumab
1
Tacrolimus
1
Sodium Chloride
1
Sirolimus
1
Peripheral Blood Stem Cell Transplantation
1
Pentostatin
1
N,N-dicyclohexyl-isoborneol-10-sulfonamide
1
Methotrexate
1
Magnetic Resonance Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neoplasm, Residual
×
Daunorubicin
×
Clear all
No trials found.